1. Various of health workers at a COVID-19 testing station
2. SOUNDBITE (English) Prof. Mosa Moshabela, Dean of School of Nursing and Public Health:
"The one thing we need to do in the short term is to distribute this AstraZeneca vaccine to, what we call healthier adults, as described in the study. Because they targeted people who were less than 65 and did not have core mobilities or risk factors per se."
4. Health worker at drive-thru COVID-19 testing station
5. Sign at drive-thru COVID-19 testing station
6. Various of health workers taking details of person before being tested for COVID-19
7. SOUNDBITE (English) Prof. Mosa Moshabela, Dean of School of Nursing and Public Health:
"But the way I would structure it would be that the Johnson&Johnson vaccine primarily be given to healthcare workers who are over the age of 60 or 65. And who already have core mobilities or other risk factors."
8. Various of health worker testing driver for COVID-19
9. SOUNDBITE (English) Prof. Mosa Moshabela, Dean of School of Nursing and Public Health:
"But also what could be really helpful is the fact that Oxford and AstraZeneca are already developing a booster. So if we can get that booster to us then it would really help us to get the most out of the AstraZeneca vaccine, especially if that booster is actually designed to be able to overcome the challenges we're having with the new variant in South Africa."
10. Various of health workers testing driver for COVID-19
South Africa has suspended plans to inoculate its frontline health workers with the AstraZeneca vaccine after a small clinical trial suggested that it isn't effective in preventing mild to moderate illness from the dominant variant in the country.
The suspension threw South Africa's vaccination plans into disarray just one week after the country received its first one million doses of the vaccine.
Early results of a small clinical trial showed that the shot did not prevent mild to moderate cases of COVID-19 in young adults, according to an announcement by the University of Witwatersrand, which conducted the test.
The disappointing early results indicate that an inoculation drive using the AstraZeneca vaccine - which is cheaper and easier to handle than others - may not be useful.
Dean of South Africa's school of nursing and public health Professor Mosa Moshabela said that among the possibilities being considered is giving Johnson & Johnson's single-dose vaccine, which has not yet been authorised for use anywhere, to 100-thousand healthcare workers while monitoring its efficacy against the variant.
Officials said this virus variant is more contagious, and evidence is emerging that it may be more virulent; recent studies have also shown it can infect people who have survived the original form of the virus.
(i) to check the terms of their licence agreements for use of content outside news programming and that further advice and assistance can be obtained from the AP Archive on: Tel +44 (0) 20 7482 7482 Email: firstname.lastname@example.org
(ii) they should check with the applicable collecting society in their Territory regarding the clearance of any sound recording or performance included within the AP Television News service
(iii) they have editorial responsibility for the use of all and any content included within the AP Television News service and for libel, privacy, compliance and third party rights applicable to their Territory.